KORU Medical Systems Inc(KRMD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 24 at 7:30 PM ET (Korea 9/25 08:30)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -0.04 | Insider Own | 6.7% | Shs Outstand | 46.1M | Perf Week | 1.55% |
| Market Cap | 0.15B | Forward P/E | 158.35 | EPS next Y | 152.85% | Insider Trans | 2.02% | Shs Float | 43.1M | Perf Month | 1.87% |
| Enterprise Value | 0.15B | PEG | - | EPS next Q | -0.02 | Inst Own | 55.62% | Short Float | 2.05% | Perf Quarter | -23.6% |
| Income | -0.00B | P/S | 3.35 | EPS this Y | 34.88% | Inst Trans | -0.51% | Short Ratio | 3.94 | Perf Half Y | -25.85% |
| Sales | 0.05B | P/B | 8.36 | EPS next 5Y | - | ROA | -6.8% | Short Interest | 0.88M | Perf YTD | -43.72% |
| Book/sh | 0.39 | P/C | 18.21 | EPS past 3/5Y | 33.31% -14.59% | ROE | -10.52% | 52W High | -50.51% ($6.61) | Perf Year | -17.22% |
| Cash/sh | 0.18 | P/FCF | 193.56 | Sales past 3/5Y | 13.81% 11.21% | ROIC | -8.75% | 52W Low | 6.79% ($3.06) | Perf 3Y | 16.79% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 60.02% | Gross Margin | 60.67% | Volatility(W/M) | 4.11% 3.27% | Perf 5Y | 7.21% |
| Dividend TTM | - | EV/Sales | 3.24 | Sales Y/Y TTM | 22.41% | Oper. Margin | -3.66% | ATR (14) | 0.13 | Perf 10Y | 738.46% |
| Dividend Ex-Date | - | Quick Ratio | 2.09 | EPS Q/Q | 213.33% | Profit Margin | -4.03% | RSI (14) | 46.24 | Recom | 1.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.72 | Sales Q/Q | 18.15% | SMA20 | 1.46% ($3.22) | Beta | 0.37 | Target Price | $6.25 |
| Payout | - | Debt/Eq | 0.18 | Earnings | 2026/8/5 | SMA50 | -6.79% ($3.51) | Rel Volume | 1.59 | Prev Close | $3.27 |
| Employees | 73 | LT Debt/Eq | 0.15 | EPS/Sales Surpr. | 155.56% 3.68% | SMA200 | -25.35% ($4.38) | Avg Volume(3M) | 0.22M | Price | $3.27 |
| IPO | 1994/4/5 | Option/Short | Yes/Yes | Trades | 1634 | Volume | 357,005 | Change | - |
Company
KRMD is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💉 KORU Medical Systems (KRMD) is a U.S. medical device company specializing in large-volume subcutaneous infusion solutions. It develops, manufactures, and sells portable infusion pumps and disposable consumables that enable patients with chronic conditions—such as those receiving immunoglobulin therapy—to self-administer medications at home. The company’s core competitive strengths are patient-centric convenience and its patented technology.
Over the past 1 year, on the lower side
51% below its 1-year high.
KRMD has weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +34.9% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Long-term returns are close to the market
Would have changed by +16.8% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 55.6%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
FSEG 0.00%
FEAC 0.00%
IWC 0.00%
GSSC 0.00%
OMFS 0.00%It ranks #4 in the industry
Based on market cap of $151M.
KRMD $151M PER -
ISRG $141B PER 45.8
BDX $49B PER 54.1
MDLN $46B PER 40.6
FAQ
What kind of company is KRMD?
KRMD belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of KRMD?
The market cap of KRMD is approximately $151M, ranking 4,292 within its sector.
What is the 52-week high and low for KRMD?
KRMD has recorded a 52-week high of $6.61 and a low of $3.06.
